HomeCompanyProductsDevelopment
Deutsch
Media Contact
BioChem Solutions' medicines utilize Trioxolane

The invention utilizes Trioxolane derivatives that, upon introduction to the body’s aqueous ambience, reduce and produce high-energy oxygen metabolites within the blood stream as well as activate certain receptor cells in the oropharyngeal cavity. These receptor cells cause the body to produce CD4 cells that are the precursor cells to the evolvement of lymphocytes and thereby modulate the natural immune process in the body.
      Alphamir Data
      Arthromir Data
 

Technology Overview

The use of Trioxolane helps destroy tumor cells and various microorganisms such as bacteria, viruses, parasites, and fungi. This approach to combat disease is totally different from the common practice of using toxic anti-microbial agents; rather, it utilizes the basic science within the white blood cells, called ‘the respiratory burst’. 

The respiratory burst is the process by which the body’s immune system produces bio-oxidants to destroy abnormal cells and invading micro-organisms. Trioxolane emulates this process by producing oxidative metabolites that are anti-microbial, immuno-stimulatory, and non-toxic. This approach reinforces the natural immune system in combating harmful agents and regulates the production of serotonin, prostaglandin, and inflammatory interleukins.

The most broadly successful therapy for human disease is provided by our own immune system. This includes all infectious, neoplastic, and autoimmune diseases. An intact and functioning immune system maintains a disease-free state, while a suppressed or dysfunctional immune system leaves us susceptible to a wide spectrum of maladies, almost without restriction. Trioxolane beneficially activates cells supportive of the body's immune system, and helps support production of free radicals; in turn, those free radicals materially increase the efficiency of the immune system to kill invading microorganisms.

 Home      |      Company    |    Products    |    Development    |    Media    |    Contact Us